Identification of a missense mutation (p.Leu1733Pro) in the A3 domain of von Willebrand factor in a family with type 2M von Willebrand disease

被引:1
|
作者
Shigekiyo, Toshio [1 ]
Yagi, Hikaru [1 ]
Sekimoto, Etsuko [1 ]
Shibata, Hironobu [1 ]
Ozaki, Shuji [1 ]
Matsumoto, Masanori [2 ]
机构
[1] Tokushima Prefectural Cent Hosp, Dept Hematol, 1-10-3 Kuramoto Cho, Tokushima 7700042, Japan
[2] Nara Med Univ, Dept Blood Transfus Med, Nara, Japan
关键词
Type 2M VWD; VWF A3 domain; VWF collagen-binding capacity; ABO blood type; Phenotypic variability; DIAGNOSIS; VWF; DEFECTS; BINDING; COHORT;
D O I
10.1007/s12185-019-02753-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The proband's von Willebrand factor (VWF) antigen and VWF collagen-binding capacity were 14% and 10%, respectively; his sister's were 16% and 9%, respectively; and his nephew's were 30% and 15%, respectively. No apparent loss of high-molecular weight VWF multimers was observed in the plasma of these patients. A single-nucleotide substitution of T to C was found at nucleotide position 113042 in their VWF gene, converting Leu1733 to Pro in the A3 domain. These results suggest that p.Leu1733Pro is responsible for type 2M von Willebrand disease in this family.
引用
收藏
页码:467 / 470
页数:4
相关论文
共 50 条
  • [1] Identification of a missense mutation (p.Leu1733Pro) in the A3 domain of von Willebrand factor in a family with type 2M von Willebrand disease
    Toshio Shigekiyo
    Hikaru Yagi
    Etsuko Sekimoto
    Hironobu Shibata
    Shuji Ozaki
    Masanori Matsumoto
    [J]. International Journal of Hematology, 2020, 111 : 467 - 470
  • [2] Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor
    Hilbert, L
    Fressinaud, E
    Ribba, AS
    Meyer, D
    Mazurier, C
    [J]. THROMBOSIS AND HAEMOSTASIS, 2002, 87 (04) : 635 - 640
  • [3] The Y/C1584 mutation of von Willebrand factor in type 2M von willebrand disease: frequency and clearance of von Willebrand factor
    Millar, CM
    Riddel, AF
    Griffioe, A
    Jenkin, PV
    Brown, SA
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (03) : 462 - 463
  • [4] von Willebrand factor pseuclogene conversion as the cause of type 2M and type 3 von Willebrand disease
    Enayat, M. S.
    Guilliatt, A. M.
    Chalmers, E. A.
    Wilde, J. T.
    Williams, M. D.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 77 - 77
  • [5] VON WILLEBRAND DISEASE TYPE 2A DUE TO A RARE VON WILLEBRAND FACTOR MISSENSE MUTATION
    Van Helmond, Jennifer
    Chopra, Aarushi
    Hernandez, Jessa
    Mysore, Sukrita
    Ahmed, Rafat
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 : S73 - S73
  • [6] Type 2M von Willebrand disease variant characterized by abnormal von Willebrand factor multimerization
    Casonato, A
    Pontara, E
    Sartorello, F
    Bertomoro, A
    Durante, C
    Girolami, A
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2001, 137 (01): : 70 - 76
  • [7] Identification and Functional Analysis of a Novel von Willebrand Factor Mutation in a Family with Type 2A von Willebrand Disease
    Dong, Jing
    Zhao, Xiaojuan
    Shi, Sensen
    Ma, Zhenni
    Liu, Meng
    Wu, Qingyu
    Ruan, Changgeng
    Dong, Ningzheng
    [J]. PLOS ONE, 2012, 7 (03):
  • [8] Identification and functional studies of a novel von Willebrand factor mutation in a family with type 2A von Willebrand disease
    Dong, J.
    Zhao, X.
    Wu, Q.
    Ruan, C.
    Dong, N.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 664 - 664
  • [9] Identification of a homozygous missense mutation (p.Cys379Gly) in the D1 domain of von Willebrand factor propeptide in a family with type 2A (IIC) von Willebrand disease
    Shigekiyo, Toshio
    Udaka, Kengo
    Shigekiyo, Toshio
    Shibata, Hironobu
    Ozaki, Shuji
    Higuchi, Yukio
    Matsumoto, Masanori
    [J]. HAEMOPHILIA, 2018, 24 (06) : E422 - E425
  • [10] von Willebrand factor alloantibodies in type 3 von Willebrand disease
    Kotnik, Barbara Faganel
    Strandberg, Karin
    Debeljak, Marusa
    Kitanovski, Lidija
    Jazbec, Janez
    Benedik-Dolnicar, Majda
    Bakija, Alenka Trampus
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (01) : 77 - 79